EMA — authorised 26 January 1999
- Marketing authorisation holder: MERCK SHARP & DOHME B.V.
- Status: approved
EMA authorised Temodar on 26 January 1999
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 26 January 1999.
MERCK SHARP & DOHME B.V. holds the EU marketing authorisation.